These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9108885)

  • 1. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.
    Asbell SO; Vijayakumar S
    Prostate; 1997 Apr; 31(1):42-6. PubMed ID: 9108885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.
    Vijayakumar S; Weichselbaum R; Vaida F; Dale W; Hellman S
    Cancer J Sci Am; 1996; 2(4):225-33. PubMed ID: 9166537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.
    Vijayakumar S; Winter K; Sause W; Gallagher MJ; Michalski J; Roach M; Porter A; Bondy M
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):17-25. PubMed ID: 9422553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
    Abdalla I; Ray P; Vaida F; Vijayakumar S
    Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
    Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
    Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
    J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.
    Zagars GK; Pollack A; Pettaway CA
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):517-23. PubMed ID: 9806509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.
    Vijayakumar S; Karrison T; Weichselbaum RR; Chan S; Quadri SF; Awan AM
    Cancer Epidemiol Biomarkers Prev; 1992; 1(7):541-5. PubMed ID: 1284591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
    Fowler JE; Bigler SA
    Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.
    Jani AB; Vaida F; Hanks G; Asbell S; Sartor O; Moul JW; Roach M; Brachman D; Kalokhe U; Muller-Runkel R; Ray P; Ignacio L; Awan A; Weichselbaum RR; Vijayakumar S
    Int J Cancer; 2001 Dec; 96(6):363-71. PubMed ID: 11745507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses.
    Lee LN; Barnswell C; Torre T; Fearn P; Kattan M; Potters L
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):282-9. PubMed ID: 12023131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research.
    Johnstone PA; Kane CJ; Sun L; Wu H; Moul JW; McLeod DG; Martin DD; Kusuda L; Lance R; Douglas R; Donahue T; Beat MG; Foley J; Baldwin D; Soderdahl D; Do J; Amling CL
    Radiology; 2002 Nov; 225(2):420-6. PubMed ID: 12409575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race and the Will Rogers phenomenon in prostate cancer.
    Vijayakumar S; Vaida F; Weichselbaum R; Hellman S
    Cancer J Sci Am; 1998; 4(1):27-34. PubMed ID: 9467043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.
    Wolf MS; Knight SJ; Lyons EA; Durazo-Arvizu R; Pickard SA; Arseven A; Arozullah A; Colella K; Ray P; Bennett CL
    Urology; 2006 Jul; 68(1):89-93. PubMed ID: 16844451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
    J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer.
    Kang JS; Maygarden SJ; Mohler JL; Pruthi RS
    BJU Int; 2004 Jun; 93(9):1207-10. PubMed ID: 15180606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer.
    Abdalla I; Ray P; Ray V; Vaida F; Vijayakumar S
    Urology; 1998 Feb; 51(2):300-5. PubMed ID: 9495715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.